SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-048105
Filing Date
2022-08-15
Accepted
2022-08-15 17:03:42
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_bluewater.htm   iXBRL 10-Q 734425
2 CERTIFICATION f10q06223ex31-1_bluewater.htm EX-31.1 11007
3 CERTIFICATION f10q06223ex31-2_bluewater.htm EX-31.2 10523
4 CERTIFICATION f10q06223ex32-1_bluewater.htm EX-32.1 3278
5 CERTIFICATION f10q06223ex32-2_bluewater.htm EX-32.2 3452
6 GRAPHIC image_001.jpg GRAPHIC 17071
  Complete submission text file 0001213900-22-048105.txt   4389117

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bwv-20220630.xsd EX-101.SCH 49951
8 XBRL CALCULATION FILE bwv-20220630_cal.xml EX-101.CAL 24388
9 XBRL DEFINITION FILE bwv-20220630_def.xml EX-101.DEF 220254
10 XBRL LABEL FILE bwv-20220630_lab.xml EX-101.LAB 447606
11 XBRL PRESENTATION FILE bwv-20220630_pre.xml EX-101.PRE 233343
53 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_bluewater_htm.xml XML 436818
Mailing Address 2041 COURTLAND AVENUE CINCINNATI OH 45212
Business Address 2041 COURTLAND AVENUE CINCINNATI OH 45212 646-303-0737
Blue Water Vaccines Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 221166531
SIC: 2834 Pharmaceutical Preparations